Inter-fraction motion robustness in a prospective phase II trial on dose-escalated proton reirradiation for locally recurrent rectal cancer

MLA

C.G. Truelsen, et al. “Inter-Fraction Motion Robustness in a Prospective Phase II Trial on Dose-Escalated Proton Reirradiation for Locally Recurrent Rectal Cancer.” Physics and Imaging in Radiation Oncology, vol. 31, no. 100634-, July 2024. EBSCOhost, https://doi.org/10.1016/j.phro.2024.100634.

APA

C.G. Truelsen, H.S. Rønde, J.F. Kallehauge, L.Ø. Poulsen, B.M. Havelund, B.G. Pedersen, L.H. Iversen, K.G. Spindler, & C.S. Kronborg. (2024). Inter-fraction motion robustness in a prospective phase II trial on dose-escalated proton reirradiation for locally recurrent rectal cancer. Physics and Imaging in Radiation Oncology, 31(100634-). https://doi.org/10.1016/j.phro.2024.100634

Chicago

C.G. Truelsen, H.S. Rønde, J.F. Kallehauge, L.Ø. Poulsen, B.M. Havelund, B.G. Pedersen, L.H. Iversen, K.G. Spindler, and C.S. Kronborg. 2024. “Inter-Fraction Motion Robustness in a Prospective Phase II Trial on Dose-Escalated Proton Reirradiation for Locally Recurrent Rectal Cancer.” Physics and Imaging in Radiation Oncology 31 (100634-). doi:10.1016/j.phro.2024.100634.